drugset / Trial / NCT07008443

An Integrated Artificial Intelligence Approach for Predicting Analgesic Time Based on Nalbuphine Versus Morphine as Adjuvants to Bupivacaine in Ultrasound-Guided Supraclavicular Block

NCT07008443

Phase 4 Completed 60 enrolled Alzahraa Ahmed Abbas
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study investigated the effect of adding nalbuphine or morphine to bupivacaine for supraclavicular brachial plexus block in upper limb surgeries. Sixty adult patients were randomized into three groups: control (bupivacaine + saline), nalbuphine, and morphine. The primary objective was to compare the duration of analgesia between the groups. A secondary goal was to assess whether artificial intelligence (AI), specifically the k-nearest neighbor (KNN) algorithm, could predict analgesic duration based on patient clinical and demographic data. The study concluded that both nalbuphine and morphine significantly prolonged analgesic duration and that the AI model showed high predictive accuracy.

Timeline

Start
2024-01-01
Primary completion
2025-04-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 50 ug/kg Other
Subject Nalbuphine Small molecule 50 ug/kg Other
Comparator Bupivacaine Other / unclassified 0.5 % Other
Comparator Bupivacaine Other / unclassified 25 ml Other

Indications

No indication recorded.